These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2863596)

  • 41. [Coronary thrombolysis after intracoronary and intravenous administration of streptokinase to myocardial infarct patients].
    Dorogun BN; Smirnov AA; Dobrovol'skiĭ AB; Pomerantsev EV; Staroverov II
    Kardiologiia; 1987 Mar; 27(3):9-14. PubMed ID: 3586489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coronary thrombolysis for evolving myocardial infarction.
    Spann JF; Sherry S
    Drugs; 1984 Nov; 28(5):465-83. PubMed ID: 6391890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Intravenous systemic thrombolysis using streptokinase in the treatment of developing cardiogenic shock in myocardial infarct].
    Dvorák K
    Vnitr Lek; 1990 May; 36(5):426-34. PubMed ID: 2375073
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An interim report of a double-blind placebo-controlled recanalisation study of anisoylated plasminogen streptokinase activator complex in acute myocardial infarction.
    Timmis AD; Griffin B; Crick JC; Flax JS; Sowton E
    Drugs; 1987; 33 Suppl 3():146-50. PubMed ID: 3315582
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ESPRIT: a European study of the prevention of reocclusion after initial thrombolysis with duteplase in acute myocardial infarction.
    Malcolm AD; Keltai M; Walsh MJ
    Eur Heart J; 1996 Oct; 17(10):1522-31. PubMed ID: 8909909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Early systemic thrombolysis in acute myocardial infarction: clinical and angiographic results].
    Rodríguez JA; Corbalán R; Kunstmann S; González R; Marchant E; Urrutia J; Codner E; Zepeda S
    Rev Med Chil; 1991 Jan; 119(1):22-6. PubMed ID: 1824139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prevention of myocardial damage in acute myocardial ischemia by early treatment with intravenous streptokinase.
    Koren G; Weiss AT; Hasin Y; Appelbaum D; Welber S; Rozenman Y; Lotan C; Mosseri M; Sapoznikov D; Luria MH
    N Engl J Med; 1985 Nov; 313(22):1384-9. PubMed ID: 4058533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Early thrombolysis improves the long-term prognosis for patients with a heart infarct].
    Vos J; Tijssen JG; Vermeer F; Verheugt FW; Krauss XH; Simoons ML
    Ned Tijdschr Geneeskd; 1990 Apr; 134(15):766-70. PubMed ID: 2336114
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of intracoronary streptokinase infusion and verapamil treatment on the size of the affected area in myocardial infarct patients].
    Vasil'tsev IaS; Karpov RS; Markov VA; Varvarenko VI; Kun VI
    Kardiologiia; 1986 Aug; 26(8):58-63. PubMed ID: 3761850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Intravenous streptokinase infusions in acute myocardial infarction. Restoring patency of occluded thrombotic coronary vessels (author's transl)].
    Schröder R; Biamino G; von Leitner ER; Linderer T
    Dtsch Med Wochenschr; 1981 Mar; 106(10):294-301. PubMed ID: 7472157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparison of intravenous and intracoronary streptokinase in acute myocardial infarction.
    Woollard KV; Mews GC; Cope GD; Cumpston N; Ireland MA; Davis MJ; Black AJ; Taylor RR
    Aust N Z J Med; 1984 Aug; 14(4):475-8. PubMed ID: 6596060
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial.
    Kennedy JW; Martin GV; Davis KB; Maynard C; Stadius M; Sheehan FH; Ritchie JL
    Circulation; 1988 Feb; 77(2):345-52. PubMed ID: 3276409
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The bidirectional association between atrial fibrillation and myocardial infarction.
    Frederiksen TC; Dahm CC; Preis SR; Lin H; Trinquart L; Benjamin EJ; Kornej J
    Nat Rev Cardiol; 2023 Sep; 20(9):631-644. PubMed ID: 37069297
    [TBL] [Abstract][Full Text] [Related]  

  • 54. ST-segment elevation myocardial infarction: Historical perspective and new horizons.
    Zijlstra F; Suryapranata H; de Boer MJ
    Neth Heart J; 2020 Aug; 28(Suppl 1):93-98. PubMed ID: 32780338
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risks and Benefits of Thrombolytic, Antiplatelet, and Anticoagulant Therapies for ST Segment Elevation Myocardial Infarction: Systematic Review.
    Nascimento BR; de Sousa MR; Demarqui FN; Ribeiro AL
    ISRN Cardiol; 2014; 2014():416253. PubMed ID: 24653840
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An alternate pathophysiologic paradigm of sepsis and septic shock: implications for optimizing antimicrobial therapy.
    Kumar A
    Virulence; 2014 Jan; 5(1):80-97. PubMed ID: 24184742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reperfusion therapy of acute ischaemic stroke and acute myocardial infarction: similarities and differences.
    Widimsky P; Coram R; Abou-Chebl A
    Eur Heart J; 2014 Jan; 35(3):147-55. PubMed ID: 24096325
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Short- and long-term mortality after myocardial infarction in patients with and without diabetes: changes from 1985 to 2008.
    Nauta ST; Deckers JW; Akkerhuis KM; van Domburg RT
    Diabetes Care; 2012 Oct; 35(10):2043-7. PubMed ID: 22815296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes in clinical profile, treatment, and mortality in patients hospitalised for acute myocardial infarction between 1985 and 2008.
    Nauta ST; Deckers JW; Akkerhuis M; Lenzen M; Simoons ML; van Domburg RT
    PLoS One; 2011; 6(11):e26917. PubMed ID: 22073220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early antimicrobial therapy in severe sepsis and septic shock.
    Kumar A
    Curr Infect Dis Rep; 2010 Sep; 12(5):336-44. PubMed ID: 21308515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.